GENE ONLINE|News &
Opinion
Blog

2021-12-16| In-DepthSpecial

ASH 2021: Understanding the Crosstalk between Acute Leukemia and Down Syndrome for Designing Better Therapies

by Sahana Shankar
Share To
Down syndrome (DS), characterized by an extra copy of chromosome 21, is a developmental disorder. Children born with DS have an irregular immune system, protecting them from certain diseases such as solid tumors, while increasing their risk of others, like leukemia. For patients with DS when diagnosed with leukemia, the compromised immune system also necessitates revision of anti-cancer regimens and supportive care, compared to other leukemia patients.  At the 63rd annual meeting of the American Society of Hematology, clinicians shared the latest clinical data and their experiences of treating children with Down Syndrome and leukemia. In a 15 minute session, three speakers presented the executive summaries of their latest work and responded to questions from the audience.

It's free! Log in now to read

LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top